We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
The act establishes a framework for collecting fees related to the regulation of OTC monograph drugs to support their review and oversight. The act allows the assessment and collection of fees from ...
Add Yahoo as a preferred source to see more of our stories on Google. Industry observers are seeking further clarity on the FDA's latest UDI guidance to avoid potential misinterpretation of the ...
SILVER SPRING, Md., Nov. 7, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in ...
On Thursday the Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter monograph drug products for the ...
In addition, FDA agreed to submit to the district court and to the NRDC status reports every 6 months (until each monograph is completed) containing a description of the actions taken by FDA to meet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results